Filing Flows › Comparisons › ZYME vs EQ
Zymeworks vs Equillium: ZYME and EQ compared
Zymeworks is the larger company: $4.6M of revenue in its latest quarter (Q2 2026) against $4.4M for Equillium (Q4 2024). Equillium is growing faster (-52% against -91% a year earlier). Equillium is more profitable, with an operating margin of -107.0% against -919.0%.
Where the money goes: ZYME and EQ
Zymeworks (ZYME) · Q2 2026
Zymeworks, Q2 2026: revenue $4.6M (-91% year over year), operating margin -919.0%, net loss $45.0M, operating cash flow −$31.9M. The chart follows the revenue to costs, profit and cash.
Equillium (EQ) · Q4 2024
Equillium, Q4 2024: revenue $4.4M (-52% year over year), operating margin -107.0%, net loss $5.8M, operating cash flow −$3.3M. The chart follows the revenue to costs, profit and cash.
| Zymeworks (ZYME) | Equillium (EQ) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q4 2024 |
| Revenue | $4.6M | $4.4M |
| Revenue growth, Y/Y | -91% | -52% |
| Operating margin | -919.0% | -107.0% |
| Net earnings | −$45.0M | −$5.8M |
| Net margin | -980.8% | -131.9% |
| Operating cash flow | −$31.9M | −$3.3M |
| Market value | $1.9B | — |
| Analysts’ mean target | $41.50 | — |
Questions
Which is bigger, Zymeworks or Equillium?
Zymeworks is the larger company: $4.6M of revenue in its latest quarter (Q2 2026) against $4.4M for Equillium (Q4 2024).
Is Zymeworks or Equillium growing faster?
Equillium is growing faster (-52% against -91% a year earlier).
Which is more profitable, Zymeworks or Equillium?
Equillium is more profitable, with an operating margin of -107.0% against -919.0%.
More: Zymeworks earnings · how Zymeworks makes money · Equillium earnings · how Equillium makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 6, 2026; 10-K filed Mar 27, 2025). Fiscal quarters can end on different dates. Not investment advice.